USPTO serial 79299097
DXCOVER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 14, 2021
- Examiner
- FOSTER, ALEXANDRA M.
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with DXCOVER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alex P. Garens
Alex P. Garens Day Pitney LLP605 Third Avenue, 31st FloorNew York, NY 10158-1803UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific apparatus and instruments for analysing biofluids and detecting diseases; laboratory apparatus and instruments for microscopy; scientific apparatus, namely, spectrometers and parts and fittings therefor; spectroscopes; scientific apparatus, namely, spectrophotometers for measuring the infrared spectrum of biofluids for the purpose of detecting diseases; spectrometry apparatus; spectrograph apparatus; data processing equipment, namely, couplers; downloadable computer software for use in medical and clinical analysis and disease diagnostics for analyzing medical data to assist in providing clinical interpretations; computer hardware; downloadable electronic publications in the nature of newsletters, reports and brochures in the field of science and medicine; data processing apparatus with artificial intelligence; downloadable artificial intelligence and machine learning software for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; research laboratory analysers for measuring, testing and analysing blood and other bodily fluids; parts and fittings for all the aforesaid goods; all of the aforesaid goods relating to spectroscopic analysis | ACTIVE | — |
| 010 | Medical apparatus and instruments for analysing biofluids and detecting diseases; diagnostic apparatus for medical purposes, namely, analysing biofluids and detecting diseases; medical apparatus for the treatment of cancer; blood testing apparatus; medical diagnostics instruments and apparatus for the analysis of bodily fluids; medical apparatus, instruments and devices for liquid biopsy analysis; parts and fittings for all the aforesaid goods; all of the aforesaid goods relating to spectroscopic analysis | ACTIVE | — |
| 042 | Scientific and technological services, namely, research, design, analysis and testing in the field of medical and clinical analysis and disease diagnostics; industrial analysis and research services in the field of medical and clinical analysis and disease diagnostics; design and development of computer hardware and software; design and development of computer software for use with medical technology; engineering services and design services for scientific equipment and apparatus for microscopy, spectroscopy and scientific imaging; medical research services; clinical research in the field of biofluid analysis and disease detection; medical laboratory services; computer programming in the medical field; design and development of medical technology; design and development of medical diagnostic apparatus; blood analysis services; scientific research for medical purposes in the area of cancerous diseases; research in the field of artificial intelligence; providing on-line non-downloadable software using artificial intelligence for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; software as a service (SaaS) services featuring software using artificial intelligence for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; software as a service (SaaS) services featuring software for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; analysis and evaluation of technical data, namely, scientific and medical data for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; technical support services, namely, computerised analysis of technical data; scientific and technological services, namely, overseeing, monitoring and managing scientific and medical experiments and tests in the field of medical and clinical analysis and disease diagnostics; scientific and technological services, namely, overseeing, monitoring and managing the analysis and evaluation of scientific and medical data in the field of medical and clinical analysis and disease diagnostics; design of scientific experiments; provision of scientific reports relating to scientific research in the field of medical and clinical analysis and disease diagnostics; advice, information and consultancy services for all of the aforesaid services; all of the aforesaid services relating to spectroscopic analysis | ACTIVE | — |
| 044 | Medical services; medical care services; health clinic services; healthcare services, namely, medical analysis services for diagnostic and treatment purposes; medical diagnostic testing, monitoring, and reporting services; providing cancer screening services; preparation of medical reports relating to health care matters in the field of biofluid analysis and the detection of diseases for medical professionals and patients; medical testing for diagnostic or treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for the diagnosis of cancer; medical testing of blood; medical testing in the nature of liquid biopsy testing for medical purposes; advice, information and consultancy services for all of the aforesaid services; all of the aforesaid services relating to spectroscopic analysis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DXCOVER LIMITED
- Other trademarks owned by Clinspec Diagnostics Limited
- Other trademarks owned by DXCOVER LIMITED
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DXCOVER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 14, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 21, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 1, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 1, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 14, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 14, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 11, 2021 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jul 2, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 1, 2021 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jun 1, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 1, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 15, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 12, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 26, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 26, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 26, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 26, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 26, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 24, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 23, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 23, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 22, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 4, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 4, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 22, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 21, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 17, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 8, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 4, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 3, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |